Description
Erlonat (Erlotinib) 150mg Online
Erlonat (Erlotinib) is used for pancreatic cancer or non-small cell lung cancer (NSCLC). Its mode of action involves inhibiting the ability of the cancer cells to multiply. The active ingredient in this anti-cancer medication is known as a tyrosine kinase inhibitor. After administration, it binds to the tyrosine kinase enzyme and blocks the activation of the epidermal growth factor. As a result of this, the cancer cells are unable to multiply. In some cases, this medicine has been used for lung cancer in patients that have failed to respond to other medicines.
Erlonat 150mg medicines are used for the treatment of non-small cell lung cancer (NSCLC) and Pancreatic. Erlonat Natco works by lessening disease cell development. Erlotinib specifically focuses on the Epidermal Growth Factor Receptor (EGFR). Erlonat 150mg Tablet is an anti-cancer medicine. Its works by hindering the action of the abnormal protein that signals cancer cells to increase. This helps to stop or moderate the spread of cancer cells. In cancer, certain cells in the body grow and multiply in a way that is ‘out of control’. Erlotinib inhibits the way the cells grow and increase in number. It works by interfering with certain enzymes called tyrosine kinases that are important in transmitting the chemical signals needed for essential processes like cell division and replication in cancer cells. This in turn stops the cancer cells from growing and increasing in number.